Transaction · 0001464521-26-000135

Rogers Campbell

Rogers Campbell, CMO, reported a transaction classified as exercise at Heartflow, Inc. involving 9219.000000 shares for an estimated $175161.00. Reported holdings after the transaction were 95678.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCMO
HTFLHeartflow, Inc.
Filing timeAug 20
Trade dateAug 17, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$46.80
Pre-filing
1mo ago -46.8%1w ago -37.3%1d ago -10.1%
Returns since
7d +2.8%30d +7.8%90d +7.8%180d +7.8%1y +7.8%

HTFL price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
HTFL since 2026-08-20Filed 16 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001464521-26-000135
Common Stock
Transaction date
Aug 17, 2026
Filed Aug 20, 2026, 01:04 AM · 3d delay
Shares
9.21k sh
$1.90k per share
Estimated value
$17.5M
Computed from shares × price
Holdings after
95.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 12, 2025.

  2. F2

    The option vests and becomes exercisable in monthly installments until August 7, 2029, subject to continued service through the applicable vesting date.

Original filing · 0001464521-26-000135
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

HTFL